Literature DB >> 29554869

Relationship between time elapsed since completion of radiotherapy and quality of life of patients with breast cancer.

Jing-Jie Zhang1, Hang Shu2, Shuai-Shuai Hu2, Yang Yu2, Yi Sun2, Yin Lv3.   

Abstract

BACKGROUND: To investigate the relationship between time elapsed since completion of radiotherapy (RT) and quality of life (QOL) of patients with breast cancer.
METHODS: A total of 300 patients with breast cancer were treated at the First Affiliated Hospital of Anhui Medical University between January 2013 and April 2016. Of these, 212 patients were included in the study. Patients were divided into 4 groups based on the time elapsed since completion of RT. The generic cancer questionnaire, EORTC QLQ-30, and the breast cancer-specific questionnaire, QLQ-BR23, were used to assess the QOL.
RESULTS: Analysis of time elapsed since completion of RT and QOL revealed changes in the scores for role function with passage of time; the third year's scores were the highest. Pain symptoms during the 3rd and 4th years after RT were lower than those during the 1st and 2nd years after RT; scores for financial difficulties fluctuated with passage of time; perception of own body scores improved within first 3 years; sexual activity and enjoyment of sexual activity showed a significant decrease during the 2nd to 4th year post RT. Scores pertaining to concerns about future state of health showed a significant increase during the 2nd to 4th year after RT, while breast symptoms score showed fluctuations with passage of time.
CONCLUSIONS: Social function, pain symptoms, and concerns about future state of health tended to improve with passage of time after RT. Other scales showed no correlation with time elapsed since completion of RT.

Entities:  

Keywords:  Breast cancer; EORTC; Quality of life; Time after Radiotherapy

Mesh:

Year:  2018        PMID: 29554869      PMCID: PMC5859708          DOI: 10.1186/s12885-018-4207-y

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


Background

Globally, breast cancer is the most common malignancy and the leading cause of cancer-related deaths among women [1, 2]. In the United States, one in eight women will develop breast cancer during their lifetime [3]. Management of breast cancer includes surgery followed by radiotherapy (RT). Other treatment approaches include chemotherapy, endocrine therapy, and molecular targeted therapy [4]. Breast cancer remission in most cases is accompanied by concomitant short and/or long term damage to the physiological structure and function [5-10]. This could ultimately limit the patients’ activities of daily living and represent a source of long term impairment [8-14]. Advances in early diagnosis and treatment of breast cancer have helped improve patient survival. Consequently, the number of people living with disease sequelae is projected to increase over time. Providing long-term health care to these patients and measuring the impact of these services are pragmatic approaches. Assessment of cancer-specific quality of life (QOL) is an ideal approach towards this end. The European Organization Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire is a widely used instrument to assess the QOL of cancer patients [15]. Its specific module on breast cancer is the EORTC QLQ-BR23 [16]. Several studies have focused on the association between various treatment modalities (such as, surgical approach, radiation and chemotherapy regime or endocrine therapy) and QOL of patients with breast cancer [17]. However, few studies have investigated the temporal changes in QOL of these patients after completion of radiotherapy. In the present study, we assessed the QOL of breast cancer patients at different time intervals after completion of RT using EORTC QLQ-C30 and EORTC QLQ-BR23 questionnaires. The objective was to assess whether time elapsed since completion of RT has a bearing on the QOL of these patients.

Methods

Study design

Patients with breast cancer were recruited at the Department of Radiation Oncology at the First Affiliated Hospital of Anhui Medical University, from January 2013 to April 2016. Breast cancer patients who received RT post surgery were enrolled in the study. Written informed consent was obtained from all patients prior to their enrolment. The study was approved by the ethics committee of The First Affiliated Hospital of Anhui Medical University.

Implementation of questionnaire survey

Patients were divided into four groups based on time elapsed since completion of radiotherapy (0–1.5 years; 1.5–2.5 years; 2.5–3.5 years; and 3.5–4.5 years). Patients were administered both EORTC QLQ-C30 and QLQ-BR23 questionnaires. QLQ-C30 is a generic questionnaire used to assess patients with various tumors, while QLQ-BR23 is a breast cancer-specific questionnaire.

Statistical analysis

Epidata 3.0 was used for data entry. Data are presented as mean ± standard deviation (SD) or as frequencies (percentages). ANOVA test was used to compare the QOL at different time intervals post RT. Multiple regression model was used to conduct multivariate analysis. Variables included in the model were age, educational level, surgical technique, surgical staging, number of chemotherapy cycles, and time elapsed since completion of RT. All statistical analyses were performed using SSPS 13.0 (SAS Institute, Inc., Cary, North Carolina); p values < 0.05 were considered statistically significant.

Results

Patient characteristics

A total of 300 patients who had undergone surgery for breast cancer were enrolled in the study; Patients were followed up in March 2017. The valid number of patients is 212 (80 patients were lost to follow-up and eight patients died). The median follow-up time was 27.2 months. The number of patients followed up for 0 to 1.5 years, 1.5 to 2.5 years, 2.5 to 3.5 years and 3.5 to 4.5 years were 64, 61, 66 and 21, respectively. Patient characteristics are listed in Table 1. The mean (±SD) age of patients was 48.36 ± 8.95 years. About 11.3% of patients were illiterate; 28.8% were educated up to primary school level, 43.9% were educated up to middle school and 16.0% of patients were educated up to college level or above. More than 95.3% of patients were married. Most patients had stage II (53.3%) or III (37.3%) disease. Percentages of patients who had received breast-conserving surgery, breast reconstruction surgery and modified radical mastectomy were 22.2%, 5.2% and 72.6%, respectively (Table 1).
Table 1

Patients’ characteristics

VariablesMean ± SD or n (%)
Age (years)48.36 ± 8.95
Level of educationIlliterate24 (11.3)
Primary School61 (28.8)
Middle School93 (43.9)
College or above34 (16.0)
Marital statusUnmarried10 (4.7)
Married202 (95.3)
Clinical stage02 (0.9)
I11 (5.2)
II113 (53.3)
III79 (37.3)
IV7 (3.3)
Surgical techniqueBreast-conserving surgery47 (22.2)
Breast reconstruction surgery11 (5.2)
Modified radical mastectomy154 (72.6)
Patients’ characteristics

Univariate analysis of EORTC QLQ-C30 data

Of the 15 subscales, only the role function, social function, pain and financial impact of disease scores exhibited significant changes over time after radiotherapy (p < 0.002). Of these, the role function score showed the highest level in the 2.5 to 3.5 years time window post-radiotherapy. Pain scores in the 2.5 to 4.5 years time window post- radiotherapy were significantly lower than those in the 0 to 2.5 years time window, which indicates subsidence of pain over time. The scores for financial impact of disease showed fluctuations over time (45.83 ± 33.60, 42.86 ± 36.67, 18.10 ± 29.53 and 53.33 ± 50.18 in the 0–1.5; 1.5–2.5; 2.5–3.5; and 3.5–4.5 years groups, respectively). The economic impact was found to be lower during the time window of 2.5 to 3.5 years since completion of RT. The total QOL score did not change significantly in different time intervals post RT with respect to the other subscales of function and clinical symptoms (Table 2).
Table 2

Results of univariate analysis of EORTC QLQ-C30 questionnaire data

ScaleTime elapsed since completion of radiotherapyF-valuep-value
 Functional scales0–1.5 years1.5–2.5 years2.5–3.5 years3.5–4.5 years
 Physical function72.50 ± 28.1771.43 ± 22.2781.71 ± 24.9190.00 ± 25.381.6430.184
 Role function88.28 ± 17.9482.86 ± 25.5695.71 ± 9.5685.00 ± 24.152.7150.048
 Emotional function89.38 ± 21.5490.00 ± 13.9384.00 ± 20.7581.00 ± 21.831.0540.372
 Cognitive function76.56 ± 22.8480.00 ± 17.9971.43 ± 30.4077.50 ± 14.190.7880.503
 Social function80.73 ± 25.7979.52 ± 16.7193.33 ± 16.2791.67 ± 11.794.0140.009
Symptom scales
 Tiredness26.82 ± 29.8323.38 ± 28.4320.53 ± 27.593.99 ± 12.621.8010.151
 Nausea/vomiting2.08 ± 7.023.81 ± 17.663.33 ± 9.740.00 ± 0.000.3290.804
 Pain35.42 ± 31.6137.14 ± 33.1118.10 ± 29.5316.67 ± 23.573.2610.024
 Shortness of breath9.38 ± 29.615.71 ± 23.5511.43 ± 32.2810.00 ± 31.620.2380.870
 Sleep disturbance9.38 ± 17.426.67 ± 17.7114.29 ± 23.2710.00 ± 31.620.7900.502
 Lack of appetite9.38 ± 29.618.57 ± 28.408.57 ± 28.4010.00 ± 31.620.0110.998
 Constipation7.29 ± 18.423.81 ± 10.766.67 ± 13.5320.00 ± 42.162.0130.116
 Diarrhea3.13 ± 17.681.43 ± 8.451.43 ± 8.450.00 ± 0.000.2430.866
 Financial impact of disease45.83 ± 33.6042.86 ± 36.6718.10 ± 29.5353.33 ± 50.185.1070.002
 Overall state of health76.82 ± 14.1676.67 ± 14.1268.10 ± 24.6376.67 ± 10.101.8630.140
Results of univariate analysis of EORTC QLQ-C30 questionnaire data

Univariate analysis of EORTC QLQ-BR23 data

Statistically significant between-group differences were observed with respect to scores for perception of own body, sexual activity, enjoyment of sexual activity, concerns about future state of health and symptoms in the breast (P < 0.05). The scores for perception of own body increased during the 0 to 3.5 years time window after RT, and then decreased during the 3.5 to 4.5 years time window. Similar trend was observed with respect to the subscales of sexual activity and enjoyment of sexual activity in that the scores dropped significantly during the 2.5 to 4.5 year time window as compared to those during the 0 to 2.5 year time window after completion of RT. On the contrary, the scores for concerns about future state of health rose significantly during the 2.5 to 4.5 year time window as compared with that during the 0 to 2.5 year time window after completion of RT. The scores for subscale of symptoms in the breast fluctuated; the highest scores pertained to the 0 to 1.5 year time window after completion of RT (Table 3).
Table 3

Results of univariate analysis of EORTC QLQ-BR23 questionnaire data

ScaleTime elapsed since completion of radiotherapyF-valuep-value
 Functional scales0–1.5 years1.5–2.5 years2.5–3.5 years3.5–4.5 years
 Perception of own body82.29 ± 25.0290.24 ± 14.5094.52 ± 11.0688.33 ± 15.812.8000.043
Sexual activity81.77 ± 26.2289.52 ± 22.1771.90 ± 27.0576.67 ± 35.312.7350.047
 Enjoyment of sexual activity83.33 ± 26.7691.43 ± 20.3671.43 ± 28.1776.67 ± 35.313.5460.017
 Concerns about future state of health71.88 ± 33.4574.29 ± 30.6192.86 ± 17.7585.00 ± 24.154.0480.009
Symptom scales
 Side-effects of therapy23.44 ± 23.5230.00 ± 28.8121.42 ± 24.1138.33 ± 23.641.5490.206
 Symptoms in the breast32.81 ± 32.0317.86 ± 20.6317.14 ± 22.5025.00 ± 16.672.8510.041
 Symptoms in arm/shoulder15.66 ± 20.4413.84 ± 18.009.31 ± 9.8820.05 ± 14.311.4800.224
 Low mood because of hair loss1.56 ± 8.844.29 ± 18.674.29 ± 14.2010.00 ± 21.080.7960.499
Results of univariate analysis of EORTC QLQ-BR23 questionnaire data

Results of multivariate linear regression analysis

On multivariate analysis, time elapsed since completion of RT was an independent predictor of social function, pain, and concerns about future state of health (p = 0.003, p = 0.011, and p = 0.013, respectively) (Tables 4 and 5).
Table 4

Variables showing no significant association with time elapsed since radiotherapy on multivariate analyses

VariablesRegression coefficientsStandard errorStandard regression coefficient t p-value
Role function
 Constant term75.36618.565
 Age0.4730.2150.2142.2000.030
 Level of education2.6092.2320.1211.1690.245
 Surgical technique−0.2202.450−0.009− 0.0900.929
 Surgical staging−5.8073.145−0.189−1.8460.068
 Number of chemotherapy cycles−0.1370.976− 0.014− 0.1410.888
 Time elapsed since completion of RT2.2311.9770.1081.1290.262
Financial impact of disease
 Constant term76.84331.830
 Age0.3920.3690.0951.0620.291
 Degree of education−14.8593.827−0.370−3.8830.000
 Surgical technique7.7934.2010.1741.8550.066
 Surgical staging−13.6315.393−0.237−2.5280.013
 Number of chemotherapy cycles2.6381.6730.1391.5760.118
 Time elapsed since completion of RT−3.2023.390−0.083−0.9440.347
Perception of own body
 Constant term32.59516.150
 Age0.4290.1870.2152.2920.024
 Level of education6.4071.9420.3293.3000.001
 Surgical technique−0.0842.131−0.004−0.0390.969
 Surgical staging4.2792.7360.1541.5640.121
 Number of chemotherapy cycles−0.5630.849−0.061− 0.6630.508
 Time elapsed since `completion of RT3.2191.7200.1731.8710.064
 Sexual activity
 Constant term60.28823.972
 Age0.8100.2780.2702.9160.004
 Level of education−4.5352.882−0.156−1.5740.119
 Surgical technique−0.9263.164−0.029− 0.2930.770
 Surgical staging3.9434.0610.0950.9710.334
Number of chemotherapy cycles−1.5961.260−0.116−1.2670.208
 Time elapsed since completion of RT−3.5472.553−0.127−1.3890.168
Enjoyment of sexual activity
 Constant term55.92823.971
 Age0.8300.2780.2742.9890.003
 Level of education−4.3522.882−0.147−1.5100.134
 Surgical technique−0.1053.164−0.003− 0.0330.974
 Surgical staging5.1844.0610.1231.2770.205
 Number of chemotherapy cycles−1.6771.260−0.120−1.3300.186
 Time elapsed since completion of RT−4.5242.553−0.160−1.7720.079
Symptoms in the breast
 Constant term42.09024.453
 Age−0.0800.283−0.028− 0.2820.778
 Level of education−1.2132.940−0.044−0.4130.681
 Surgical technique−2.5573.227−0.083−0.7920.430
 Surgical staging0.9344.1430.0240.2250.822
 Number of chemotherapy cycles0.0971.2850.0070.0760.940
 Time elapsed since completion of RT−4.4102.604−0.167−1.6930.093
Table 5

Variables showing a significant association with time elapsed since radiotherapy on multivariate analyses

VariablesRegression coefficientsStandard errorStandard regression coefficientt-valuep-value
Social function
 Constant term70.10417.984
 Age−0.1610.208−0.071−0.7700.443
 Level of education2.5002.1620.1141.1560.250
 Surgical technique−5.5852.373−0.230−2.3530.020
 Surgical staging1.7873.0470.0570.5860.559
 Number of chemotherapy cycles1.8040.9450.1751.9080.059
 Time elapsed since completion of RT5.7871.9150.2763.0220.003
Pain
 Constant term−0.57829.509
 Age0.6640.3420.1871.9410.055
 Level of education6.0303.5480.1751.7000.092
 Surgical technique−1.4813.894−0.038−0.3800.704
 Surgical staging0.9195.0000.0190.1840.854
 Number of chemotherapy cycles−0.1061.551−0.006− 0.0680.946
 Time elapsed since completion of RT−8.1183.143−0.245−2.5830.011
Concerns about future state of health
 Constant term−0.28025.906
 Age0.2370.3000.0740.7880.432
 Level of education6.0923.1150.1951.9560.053
 Surgical technique−3.3033.419−0.095−0.9660.336
 Surgical staging13.2894.3890.2973.0280.003
 Number of chemotherapy cycles−0.1311.362−0.009− 0.0960.923
 Time elapsed since completion of RT6.9742.7590.2332.5280.013
Variables showing no significant association with time elapsed since radiotherapy on multivariate analyses Variables showing a significant association with time elapsed since radiotherapy on multivariate analyses

Discussion

The present study is among the few studies which have evaluated the effect of time elapsed since completion of radiotherapy on the QOL of breast cancer patients following breast surgery using the EORTC QLQ-C30 and EORTC QLQ-BR23 instruments. We found that the patients’ social function, as measured with the EORTC QLQ-C30, improved significantly with passage of time during the 2.5 to 4.5 year time window after completion of RT. Social function refers to the patient’s self-awareness about his/her own health status and the impact on family’s daily life and social activities. A previous study revealed poor QOL of family caregivers of patients with cancers [18]. Strain imposed by cancer associated pain and discomfort, impaired capacity for work, and the dependence on drugs and adjuvant therapy can affect the physical condition of family caregivers, and render them vulnerable to cognitive dysfunction and sleep disorders. The major causes that impair post-treatment social life of patients with breast cancer include physical changes (such as removal of mammary gland), pain, and psychological factors such as depression, irritability and anxiety [19-21]. With passage of time after completion of radiotherapy, patients tend to gradually accept the reality, which helps improve their social adaptability [22-24]. Breast, arm, and shoulder pain are commonly experienced by breast cancer patients after treatment [25, 26]; these were shown to significantly impair the long-term QoL of these patients [27]. These symptoms may be attributable to tumor metastasis, anti-cancer therapy or to social-psychological factors. Previous studies have identified age, axillary lymph node dissection, and postoperative RT as significant risk factors [25, 28]. In the present study, only time elapsed since completion of RT was found to be associated with reduction in pain, after adjusting for age, educational level of patients, operation method, surgical staging and number of chemotherapy cycles; pain relief was especially noticeable after 2.5 to 4.5 years post-radiotherapy. Scores pertaining to concerns about future state of health showed improvement from 2.5 to 3.5 years post-radiotherapy and a slight decline was also observed during the 3.5 to 4.5 year time window post-radiotherapy. The diagnosis and cure of breast cancer are both typically life-changing events which affect the patient’s psychological health [29]. At initial diagnosis, the patient typically experiences the psychological phenomenon of denial, anger, acceptance, depression, fear and survival, short-term lack of confidence and even fear for future health. Although the negative effects of disease on the patient exist, the positive effects of post-traumatic growth, however, helps augment patient’s confidence and reduces their worries about future [30]. More importantly, the confidence of patients is reinforced by the negative results of the annual cancer re-examination. Additionally, the recovery of functions in various aspects promotes the normal activities of daily living, which enable the patients to look forward to the future [24]. The cross-sectional study design is the main limitation of this study. The design does not allow for causal inferences, but only describes the factors associated with self-reported QoL outcomes.

Conclusions

In this study cohort, time elapsed since completion of RT had significant impact on social function, pain symptoms, and concerns about future state of health of patients with breast cancer. These scales improved with passage of time after RT. Our results have profound guiding significance for QOL of patients with breast cancer after RT. Of note, breast cancer is a heterogeneous disease and these results are limited to the cross-sectional study. Further studies are needed to elucidate the possible impact of time elapsed since completion of RT on breast cancer patients.
  28 in total

Review 1.  Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review.

Authors:  Pamela K Levangie; Jacqueline Drouin
Journal:  Breast Cancer Res Treat       Date:  2008-11-25       Impact factor: 4.872

2.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

Authors:  M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

3.  Work status and life changes in the first year after breast cancer diagnosis.

Authors:  Aina Johnsson; Tommy Fornander; Lars-Erik Rutqvist; Mariann Olsson
Journal:  Work       Date:  2011

Review 4.  Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.

Authors:  Janice N Cormier; Robert L Askew; Kristi S Mungovan; Yan Xing; Merrick I Ross; Jane M Armer
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

5.  Comfort and quality of life in patients with breast cancer undergoing radiation therapy.

Authors:  Seda Pehlivan; Abdurrahman Kuzhan; Yasemin Yildirim; Cicek Fadiloglu
Journal:  J BUON       Date:  2016 May-Jun       Impact factor: 2.533

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery.

Authors:  Diana J Dawes; Sarkis Meterissian; Mark Goldberg; Nancy E Mayo
Journal:  J Rehabil Med       Date:  2008-08       Impact factor: 2.912

8.  Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study.

Authors:  Stanimira Krotneva; Kristen Reidel; Mohammed Nassif; Nora Trabulsi; Nancy Mayo; Robyn Tamblyn; Ari N Meguerditchian
Journal:  Breast Cancer Res Treat       Date:  2013-07-24       Impact factor: 4.872

9.  Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis.

Authors:  Catherine M Alfano; Ashley Wilder Smith; Melinda L Irwin; Deborah J Bowen; Bess Sorensen; Bryce B Reeve; Kathleen A Meeske; Leslie Bernstein; Kathy B Baumgartner; Rachel Ballard-Barbash; Kathleen E Malone; Anne McTiernan
Journal:  J Cancer Surviv       Date:  2007-06       Impact factor: 4.442

10.  Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.

Authors:  F Peintinger; R Reitsamer; H Stranzl; G Ralph
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  3 in total

1. 

Authors:  Jonatas Gomes Barbosa da Silva; Diogo Timóteo Costa; Iago Dillion Lima Cavalcanti; Mariane Cajubá de Britto Lira Nogueira; Diego Augusto Lopes Oliveira
Journal:  Can Oncol Nurs J       Date:  2022-04-01

2.  Quality of life in women with breast cancer treated at a radiotherapy centre in Caruaru, Pernambuco, Brazil.

Authors:  Jonatas Gomes Barbosa da Silva; Diogo Timóteo Costa; Iago Dillion Lima Cavalcanti; Mariane Cajubá de Britto Lira Nogueira; Diego Augusto Lopes Oliveira
Journal:  Can Oncol Nurs J       Date:  2022-04-01

3.  The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review.

Authors:  Gabriela Ilie; Jillian Bradfield; Louise Moodie; Tarek Lawen; Alzena Ilie; Zeina Lawen; Chloe Blackman; Ryan Gainer; Robert D H Rutledge
Journal:  Front Oncol       Date:  2019-08-20       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.